امبرادكس٢٠ إسرائيل - العربية - Ministry of Health

امبرادكس٢٠

dexcel ltd - omeprazole 20 mg - caplets - omeprazole - acute duodenal ulcer. acute gastric ulcer. reflux esophagitis: treatment , long - term management. maintenance treatment for the prevention of relapse in patients with severe reflux esophagitis. maintenance treatment for the prevention of relapse in patients with poorly reponsive peptic ulcer. zollinger-ellison syndrome. treatment and prevention of nsaid-associated duodenal and gastric ulcers or erosions in high risk patients. treatment of severe reflux oesophagitis in children overthe age of 6 year. helicobacter pylori - associated peptic ulcer disease in combination with antibiotics.

كارنيتين محلول ٣٠% إسرائيل - العربية - Ministry of Health

كارنيتين محلول ٣٠%

abic marketing ltd - levocarnitine 30 % - solution - levocarnitine - systemic and myopathic carnitine deficiency.

نورڤاسك ٥ ملغ إسرائيل - العربية - Ministry of Health

نورڤاسك ٥ ملغ

pfizer pharmaceuticals israel ltd - amlodipine as besylate 5 mg - tablets - amlodipine - mild to moderate hypertension. vasospastic angina ( prinzmetal's or variant angina). chronic stable angina.

نورڤاسك ١٠ ملغ إسرائيل - العربية - Ministry of Health

نورڤاسك ١٠ ملغ

pfizer pharmaceuticals israel ltd - amlodipine as besylate 10 mg - tablets - amlodipine - mild to moderate hypertension. vasospastic angina ( prinzmetal's or variant angina). chronic stable angina.

راﻣيپريل تيڤع ٥ ملغ إسرائيل - العربية - Ministry of Health

راﻣيپريل تيڤع ٥ ملغ

teva pharmaceutical indust.ltd - ramipril 5 mg - tablets - ramipril - - hypertension - congestive heart failure - reduction of mortality in patients after mi with left ventricular dysfunction for reducing the risk of myocardial infarction stoke cardiovascular death or need for revascularization procedures in patients over 55 years or more who have clinical evidence of cardiovascular disease (previous mi unstable angina or multivessel cabg or multivessel ptca) stroke or peripheral vascular disease. also for reducing the risk of myocardial infarction stroke cardiovascular death or need for revascularization procedures in diabetic patients of 55 years or more who have one or more of the following clinical findings : hypertension (systolic blood pressure > 160 mmhg or diastolic pressure > 90 mmhg) high total cholesterol (>5.2 mmol/l) low hdl ( <0.9 mmol/l) current smoker known microalbuminuria clinical evidence of previous vascular disease. - prevention of progressive renal failure in patients with persistent proteinuria in excess of 1g/day.